Highlights
IIA supported (ever)Profile claimed by owner
About
Genetically Engineered Fibrin Sealant
Fibplant is developing a genetically engineered Fibrinogen, intended to be uses as a biological glue for an existing pharma drug market.
The company's advanced active compositions are based on therapeutic proteins produced in transgenic plants, and made for Surgery and Emergency medicine.
Identity
| Name | Fibplant |
|---|---|
| Slug | fibplant |
| Type / kind | startup |
| Source _id | RBMPcXH7lliYyDB1F7YVJ9vvV5JHgKw7lnZpTja02FwLdIilCgFYyt |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | HaHashmonaim St 4, Tel Aviv-Yafo, Israel |
Web & social
| Website | https://fibplant.com/ |
|---|
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
biological-therapymolecular-biologydrug-developmentplant-genomicslife-sciencesgenetic-engineeringbioprocessbiopharmaceuticalpharmaceuticalsplant-proteinbiotechnologysurgery
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}